Molnupiravir Revisited—Critical Assessment of Studies in Animal Models of COVID-19

Molnupiravir, a prodrug known for its broad antiviral activity, has demonstrated efficacy in animal models of COVID-19, prompting clinical trials, in which initial results indicated a significant effect against the disease. However, subsequent clinical studies did not confirm these findings, leading...

Descripción completa

Detalles Bibliográficos
Autores principales: Rasmussen, Henrik Berg, Hansen, Peter Riis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675540/
https://www.ncbi.nlm.nih.gov/pubmed/38005828
http://dx.doi.org/10.3390/v15112151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675540/
https://www.ncbi.nlm.nih.gov/pubmed/38005828
http://dx.doi.org/10.3390/v15112151

Ejemplares similares